These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7681656)

  • 21. Ampligen inhibits human herpesvirus-6 in vitro.
    Ablashi DV; Berneman ZN; Williams M; Strayer DR; Kramarsky B; Suhadolnik RJ; Reichenbach N; Hiltzges P; Komaroff AL
    In Vivo; 1994; 8(4):587-91. PubMed ID: 7893986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of poly(I):poly(C12U), mismatched double-stranded RNA, by rapid solution hybridization: blood values after intravenous infusion.
    Strauss KI; Strayer DR; Gillespie DH
    J Pharm Pharmacol; 1990 Apr; 42(4):261-6. PubMed ID: 1974294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes of serum 2',5'-oligoadenylate synthetase activity and neopterin during interferon treatment for chronic hepatitis C].
    Daito K; Suou T; Kawasaki H
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):981-5. PubMed ID: 7563914
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetics and pharmacodynamics of recombinant human interferon-beta in healthy male volunteers.
    Salmon P; Le Cotonnec JY; Galazka A; Abdul-Ahad A; Darragh A
    J Interferon Cytokine Res; 1996 Oct; 16(10):759-64. PubMed ID: 8910759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind randomized phase I study on the clinical tolerance and biological effects of natural and recombinant interferon-beta.
    Liberati AM; Horisberger MA; Palmisano L; Astolfi S; Nastari A; Mechati S; Villa A; Mancini S; Arzano S; Grignani F
    J Interferon Res; 1992 Oct; 12(5):329-36. PubMed ID: 1431312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentiation of the cytocidal effect of human immune interferon by different synthetic double-stranded RNAs in the refractory human colon carcinoma cell line BE.
    Chapekar MS; Glazer RI
    Cancer Res; 1986 Apr; 46(4 Pt 1):1698-702. PubMed ID: 3081254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral activity of mismatched double-stranded RNA against human immunodeficiency virus in vitro.
    Montefiori DC; Mitchell WM
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2985-9. PubMed ID: 3106982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A clinical grade poly I:C-analogue (Ampligen) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro.
    Navabi H; Jasani B; Reece A; Clayton A; Tabi Z; Donninger C; Mason M; Adams M
    Vaccine; 2009 Jan; 27(1):107-15. PubMed ID: 18977262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and biologic effects of combination therapy with gamma-interferon and tumor necrosis factor.
    Schiller JH; Witt PL; Storer B; Alberti D; Tombes MB; Arzoomanian R; Brown RR; Proctor RA; Voss SD; Spriggs DR
    Cancer; 1992 Jan; 69(2):562-71. PubMed ID: 1728387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel PEGylated interferon beta-1a for multiple sclerosis: safety, pharmacology, and biology.
    Hu X; Miller L; Richman S; Hitchman S; Glick G; Liu S; Zhu Y; Crossman M; Nestorov I; Gronke RS; Baker DP; Rogge M; Subramanyam M; Davar G
    J Clin Pharmacol; 2012 Jun; 52(6):798-808. PubMed ID: 21680782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans.
    Schiller JH; Storer B; Paulnock DM; Brown RR; Datta SP; Witt PL; Borden EC
    J Clin Invest; 1990 Oct; 86(4):1211-21. PubMed ID: 2120284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individuals.
    Witt PL; Spear GT; Lindstrom MJ; Kessler HA; Borden EC; Phair J; Landay AL
    AIDS; 1991 Mar; 5(3):289-93. PubMed ID: 2059368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Biological actions and therapeutic perspectives of double stranded polyribonucleotides: a reappraisal].
    Thang MN; Guschlbauer W
    Pathol Biol (Paris); 1992 Dec; 40(10):1006-14. PubMed ID: 1284399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of different types of recombinant interferon on the induction of 2,5-oligoadenylate synthetase in natural killers and the tumor cells in bladder cancer patients].
    Vozianov AF; Drannik GN; Verkhatskaia AA; Zavelevich MP; Prokhnevskaia EL; Verkhatskiĭ PP; Klimenko IA
    Urol Nefrol (Mosk); 1993; (5):22-5. PubMed ID: 7508649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunomodulation of natural killer activity by polyribonucleotides.
    Wiltrout RH; Salup RR; Twilley TA; Talmadge JE
    J Biol Response Mod; 1985 Oct; 4(5):512-7. PubMed ID: 4078596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Changes in serum levels of beta 2-microglobulin, neopterin and 2',5'-oligoadenylate synthase activity during clearance of hepatitis B virus with or without acute phase in transaminases].
    Carreño García V; Hernández-Guío C; Bartolomé Nebreda J; Quiroga Estévez JA
    Rev Esp Enferm Dig; 1993 Mar; 83(3):169-75. PubMed ID: 7683894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I/IB study of polyadenylic-polyuridylic acid in patients with advanced malignancies: clinical and biologic effects.
    Witt PL; Zahir S; Ritch PS; McAuliffe TM; Ewel CH; Borden EC
    J Interferon Cytokine Res; 1996 Aug; 16(8):631-5. PubMed ID: 8877734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum and urinary neopterin levels in patients with chronic active hepatitis B treated with interferon.
    Daito K; Suou T; Kawasaki H
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):303-16. PubMed ID: 8008980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamics of recombinant IFN-beta during long-term treatment of malignant melanoma.
    Fierlbeck G; Ulmer A; Schreiner T; Stroebel W; Schiebel U; Brzoska J
    J Interferon Cytokine Res; 1996 Oct; 16(10):777-81. PubMed ID: 8910762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TLR3 is essential for the induction of protective immunity against Punta Toro Virus infection by the double-stranded RNA (dsRNA), poly(I:C12U), but not Poly(I:C): differential recognition of synthetic dsRNA molecules.
    Gowen BB; Wong MH; Jung KH; Sanders AB; Mitchell WM; Alexopoulou L; Flavell RA; Sidwell RW
    J Immunol; 2007 Apr; 178(8):5200-8. PubMed ID: 17404303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.